Kura Oncology
KURA
200 hedge funds and large institutions have $743M invested in Kura Oncology in 2025 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 77 increasing their positions, 50 reducing their positions, and 24 closing their positions.
156% more call options, than puts
Call options by funds: $7.3M | Put options by funds: $2.85M
79% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 24
57% more capital invested
Capital invested by funds: $474M → $743M (+$269M)
54% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 50
10% more funds holding
Funds holding: 182 → 200 (+18)
1.85% more ownership
Funds ownership: 94.8% → 96.65% (+1.9%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$12M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$9.27M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$7.99M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$6.15M |
| 5 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
+$4.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$23.7M |
| 2 |
AC
Armistice Capital
New York
|
-$10.9M |
| 3 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$4.71M |
| 4 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$4.24M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$4.01M |
KURA Hedge Fund Activity: Q3 2025 in Review
200 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q3 2025, worth a combined $743M — up 57% from $474M a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new KURA positions and 24 closed out — a net gain of 19 holders — while 77 added to existing stakes and 50 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $12M. The largest seller was EcoR1 Capital, cutting an estimated $23.7M.
- 200 institutional investors held Kura Oncology (KURA) as of Q3 2025, up from 182 in Q2 2025.
- Funds reported $743M of Kura Oncology stock for Q3 2025, up 57% quarter-over-quarter.
- 43 funds opened new Kura Oncology positions in Q3 2025 and 24 closed out, a net change of +19 holders.
- The largest Kura Oncology buyer in Q3 2025 was Goldman Sachs, an estimated $12M added.
- The largest Kura Oncology seller in Q3 2025 was EcoR1 Capital, an estimated $23.7M sold.
Based on aggregated 13F filings for Q3 2025.